You searched for "protection"
Can we predict how much benefit patients will get from ESS with a novel monoclonal antibody
Mepolizumab (Nucala) is a humanised IgG1 monoclonal antibody that acts as an IL-5 antagonist. It has been shown to be highly effective in treating severe asthma. It is hypothesised that it will be effective for patients with recalcitrant CRSwNP. This...Detecting hearing loss in the military: are the current methods adequate?
A team at the University of Southampton have been funded by the Ministry of Defence to investigate how to improve the assessment of auditory fitness for duty in the UK Armed Forces. Matt Blyth talks us through the current methods...RNID’s campaign to restore NHS earwax removal services in the UK
Wax removal in the UK has become a topic of intense discussion. Here, Crystal Rolfe discusses the RNID’s findings and approach to tackling the issue. Earwax build-up can cause painful and distressing symptoms – a 2022 RNID survey found people...In conversation with Dr Peter Belafsky
Dr Peter Belafsky. Peter – tell us about your background I was born in Philadelphia and went on to study at Vassar College which is a small liberal arts school in upstate New York. I then attended Medical School in...Database WG2. The Tinnitus Patient Database in the TINNET COST Action BM1306
Berthold Langguth describes an innovative project that is creating the world’s largest multi-national patient database containing standardised information on tinnitus and medical history, otological examination and psycho-acoustic measures of tinnitus. A challenge for tinnitus treatment and tinnitus research is the...
Clinical value of 3 T magnetic resonance imaging after intratympanic gadolinium injection in cases of delayed endolymphatic hydrops
Recurrent vertigo can continue after severe unilateral or bilateral hearing loss. This is a condition similar to Ménière’s disease, the diagnosis of which can be difficult. In this study intratympanic injection of gadolinium-diethylenetriamine penta-acetic acid dimeglumine was done in 25...
Persistent dysphonia due to cricothyroid muscle dystonia – should we be requesting laryngeal EMGs for non-resolving ‘functional’ dysphonia?
This article is an interesting report of a case of persistent voice problems affecting a 43-year-old physician that significantly compromised her ability to converse and communicate at work. Specifically, she had a fluctuating voice quality that would ‘choke off’, combined...Scarless thyroidectomy: the RABIT journey in robotic innovation
Surgeons in Bangalore share how a novel robotic approach enables scar-sparing thyroid surgery for large nodules and cancer, while reshaping global training. Can an 8 cm benign thyroid cystic nodule be removed without a big scar in the neck? Can...Update on the development of an implantable vestibular prosthesis
Cochlear implants have revolutionised the management of profound hearing loss. Might vestibular implants be the future for the treatment of bilateral vestibular failure? James Johnston and Neil Donnelly explore. The vestibular system is highly complex, integrating visual, labyrinthine and proprioceptive...
Immunosuppresants and ototoxicity
There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...IFOS activities
International collaboration is more important than ever, and we hear from Prof Milan Profant about a collaboration that grew out of the very successful IFOS meeting in Paris in 2017. IFOS has developed a new philosophy regarding how to organise...
